Functional disturbance of the stress-adaptation system in patients with scleroderma

Modern Rheumatology

Volumn 21, Issue 4, 2011, Pages 397-405

  Matsuura, Emi ^a,b   Ohta, Akihide ^c   Suematsu, Rie ^c   Inoue, Hisako ^c   Koarada, Syuichi ^c   Tada, Yoshifumi ^c   Sherriff Tadano, Ryoko ^d   Kuroki, Tsukasa ^e   Ikeda, Daisaku ^f   Nagasawa, Kohei ^c  

^a SAGA UNIVERSITY   (Japan)

^b Kwassui Women's College   (Japan)

^c SAGA UNIVERSITY   (Japan)

^d INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^e HIROSHIMA UNIVERSITY   (Japan)

^f KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hypothalamic pituitary adrenal axis; Neuro endocrine immune system; Scleroderma; Stress

Indexed keywords

ADRENALIN; BETA ENDORPHIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; HYDROCORTISONE; INTERLEUKIN 1; INTERLEUKIN 6; NORADRENALIN; STEROID; TUMOR NECROSIS FACTOR;

ADAPTATION; ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COPING BEHAVIOR; CYTOKINE RELEASE; DISEASE EXACERBATION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NEUROENDOCRINE SYSTEM; NEUROIMMUNOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RHEUMATIC DISEASE; SCLERODERMA; SHORT FORM 8; STRESS;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HORMONES; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; QUALITY OF LIFE; QUESTIONNAIRES; SCLERODERMA, SYSTEMIC; STRESS, PSYCHOLOGICAL;

EID: 83255164768     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-010-0412-5     Document Type: Article

References (57)

1. Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2005;54:1481-91. (Pubitemid 41375207)
2. Kuroki T, Ohta A, Aoki Y, Kawasaki S, Sugimoto N, Ootani H, et al. Stress maladjustment in the pathoetiology of ulcerative colitis. J Gastroenterol. 2007;42:522-7. (Pubitemid 47190068)
3. Crofford LJ. The hypothalamic-pituitary-adrenal axis in the pathogenesis of rheumatic diseases. Endocrinol Metab Clin Noth Am. 2002;31:1-13. (Pubitemid 34578611)
4. Elenkov IJ, Chrousos GP. Stress system: organization, physiology and immunoregulation. Neuroimmunomodulation. 2006;13: 257-67. (Pubitemid 47289508)
5. Thomason B, Brantley P, Jones G, Dyer H, Morris J. The relation between stress and disease activity in rheumatoid arthritis. J Behav Med. 1992;15:215-20.
6. Affleck G, Tennen H, Urrows S, Higgins P. Person and contextual features of daily stress reactivity: individual differences in relations of undesirable daily events with mood disturbance and chronic pain intensity. J Pers Soc Psychol. 1994;66:329-40.
7. Potter PT, Zautra AJ. Stressful life events on rheumatoid arthritis disease activity. J Consult Clin Psychol. 1997;65:319-23. (Pubitemid 27147451)
8. Marcenaro M, Prete C, Badini A, Sulli A, Magi E, Cutolo M. Rheumatoid arthritis, personality, stress response style, and coping with illness: a preliminary survey. Ann NY Acad Sci. 1999;876:419-25. (Pubitemid 29352153)
9. Neeck G, Federlin K, Graef V, Rusch D, Schmidt K. Adrenal secretion of cortisol in patients with rheumatoid arthritis. J Rheumatol. 1990;17:24-9. (Pubitemid 20070562)
10. Chikanza I, Petrou P, Kingsley G, Chrousos G, Panayi G. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum. 1992;35:1281-8.
11. Crofford LJ, Sano H, Karalis K, Friedman T, Epps H, Remmers E, et al. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. J Immunol. 1993;151:1587-96. (Pubitemid 23219297)
12. Gudbjornsson B, Skogseid B, Oberg K, Wide L, Hallgren R. Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis: effect of glucocorticoids. J Rheumatol. 1996;23:596-602. (Pubitemid 26132843)
13. Masi A, Chrousus G. Hypothalamic-pituitary-adrenal-glucocorticoid axis function in rheumatoid arthritis. J Rheumatol. 1996;23:577-81. (Pubitemid 26132840)
14. Crofford LJ, Kalogeras KT, Mastorakos G, Magiakou MA, Wells J, Kanik KS, et al. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab. 1997;82:1279-83. (Pubitemid 27166676)
15. Cutolo M, Foppiani L, Prete C, Ballarino P, Sulli A, Villaggio B, et al. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol. 1999;26:277-81.
16. Mukai E, Nagashima M, Hirano D, Yoshino S. Comparative study of symptoms and neuroendocrine-immune network mediator levels between rheumatoid arthritis patients and healthy subjects. Clin Exp Rheumatol. 2000;18:585-90.
17. Hirano D, Nagashima M, Ogawa R, Yoshino S. Serum levels of interleukin 6 and stress related substances indicate mental stress condition in patients with rheumatoid arthritis. J Rheumatol. 2001;28:490-5. (Pubitemid 32202648)
18. Costa D, Dobkin P, Pinard L, Fortin P, Danoff D, Esdaile J, et al. The role of stress in functional disability among women with systemic lupus erythematosus: a prospective study. Arthritis Care Res. 1999;12:112-9. (Pubitemid 29508679)
19. Ward M, Lotstein D, Bush T, Lambert E, Vollenhoven R, Neuwelt C. Psychosocial correlates of morbidity in women with systemic lupus erythematosus. J Rheumatol. 1999;26:2153-8. (Pubitemid 29487009)
20. Harle P, Straub R, Wiest R, Schomerich J, Atzeni F, Carrabba M, et al. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems. Ann Rheum Dis. 2006;65:51-6. (Pubitemid 41815639)
21. Zietz B, Reber T, Oertel M, Gluck T, Scholmerich J, Straub RH. Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erythematosus. II. Dissociation between androstenedione, cortisol, or dehydroepiandrosterone and interleukin 6 or tumor necrosis factor. J Rheumatol. 2000;27:911-8. (Pubitemid 30389746)
22. Gutierrez MA, Garcia ME, Rodriguez JA, Rivero S, Jacobelli S. Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus. Lupus. 1998;7:404-8. (Pubitemid 28410186)
23. Rovensky J, Blazickova S, Rauova D, Koska J, Lukac J, Vigas M. The hypothalamic-pituitary response in SLE. Regulation of prolactin, growth hormone and cortisol release. Lupus. 1998; 7:409-13.
24. Brown GW, Harris T. Stressor, vulnerability and depression: a question of replication. Psychol Med. 1986;16:739-44. (Pubitemid 17214657)
25. Imrich R, Lukac J, Rovensky J, Radikova Z, Penesova A, Kvetnansky R, et al. Lower adrenocortical and adrenomedullary responses to hypoglycemia in premenopausal women with systemic sclerosis. J Rheumatol. 2006;33:2235-41. (Pubitemid 44749783)
26. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23:581-90.
27. Fujii T, Ogino S, Arimoto H, Irifune M, Iwata N, Ookawachi I, et al. Quality of life in patients with Japanese cedar pollinosis: using the SF-8 health status questionnaire (Japanese version) (in Japanese with English abstract). Arerugi. 2006;55:1288-94. (Pubitemid 44788465)
28. Turner-Bowker DM, Bayliss MS, Ware JE Jr, Kosinski M. Usefulness of the SF-8 health survey for comparing the impact of migraine and other conditions. Qual Life Res. 2003;12:1003-12. (Pubitemid 37386628)
29. Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP. Assessment of patient satisfaction in activities of daily living using a modified Stanford health assessment questionnaire. Arthritis Rheum. 1983;26:1346-53. (Pubitemid 14231480)
30. Iwahashi S, Tanaka Y, Fukudo S, Hongo M. The development of the Japanese version of the perceived stress scale (in Japanese with English abstract). Jpn J Psychosom Med. 2002;42:459-66.
31. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385-96.
32. Antonovsky A. The structure and properties of sense of coherence scale. Soc Sic Med. 1993;36:725-33. (Pubitemid 23132355)
33. Callahan LF, Pincus T. The sense of coherence scale in patients with rheumatoid arthritis. Arthritis Care Res. 1995;8:28-35.
34. Togari T, Yamazaki Y. Examination of the reliability and factor validity of 13-item five-point version sense of coherence scale (in Japanese with English abstract). Minzoku Eisei. 2005;71:168-82.
35. Utsunomiya T, Yoshida K, Nishimura Y, Morooka T, Ohtsubo Y, Tsuji S, et al. Effects of mental stress on blood pressure and heart rate: comparison with exercise stress in normal subjects. Jpn Circ J. 2001;13:516-20.
36. Medsger T, Silman A, Steen V, Black C, Akesson A, Bacon P, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol. 1999;26:2159-67. (Pubitemid 29487010)
37. Clements P, Lachenbruch L, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (Modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22:1281-5.
38. Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW, et al. Inflammatory mediator-induced hypothalamic- pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci USA. 1989;86:2374-8. (Pubitemid 19102511)
39. Del Ray A, Wolff C, Wildmann J, Randolf A, Hahnel A, Besedovsly HO, et al. Disrupted brain-immune system-joint communication during experimental arthritis. Arthritis Rheum. 2008;58:3090-9.
40. Lechner O, Hu Y, Jafarian-Tehrani M, Dietrich H, Schwarz S, Herold M, et al. Disturbed immunoendocrine communication via the hypothalamo-pituitary- adrenal axis in murine lupus. Brain Behav Immunol. 1996;10:337-50. (Pubitemid 27116508)
41. Eskandari F, Webster JI, Sternberg EM. Neural immune pathways and their connection to inflammatory disease. Arthritis Res Ther. 2003;5:251-65. (Pubitemid 37407974)
42. Kanik KS, Chrousos GP, Schumacher HR, Crane ML, Yarboro CH, Wilder RL. Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: relations with indices of inflammation. J Clin Endocrinol Metab. 2000;85:1461-6. (Pubitemid 32289487)
43. Straub RH, Paimela L, Peltomaa R, Scholmerich J, Leirisalo M. Inadequately low serum levels steroid hormones in relation to interleukin-6 and necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum. 2002;46:654-62. (Pubitemid 34214248)
44. Straub RH, Harle P, Sarzi-Puttini P, Cutolo M. Tumor necrosis factor-neutralizing therapies improve altered hormone axes: an alternative mode of anti-inflammatory action. Arthritis Rheum. 2006;54:2039-46. (Pubitemid 44051059)
45. Straub RH, Pongratz G, Cutolo M, Wijbrandts CA, Beaten D, Fleck M, et al. Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis. Arthritis Rheum. 2008;58:976-84. (Pubitemid 351563998)
46. Bijlsma JW, Cutolo M, Straub RH, Masi AT. Clinical aspects of immune neuroendocrine mechanisms in rheumatic diseases. Rheum Dis Clin North Am. 2005;31:xiii-xvi.
47. Dekkers JC, Geenen R, Godaert GL, Bijlsma JW, van Doornen LJ. Elevated sympathetic nervous system activity in patients with recently diagnosed rheumatoid arthritis with active disease. Clin Exp Rheumatol. 2004;22:63-70. (Pubitemid 38236126)
48. Birrell FN, Hassell AB, Jones PW, Dawes PT. How does the short form 36 health questionnaire (SF-36) in rheumatoid arthritis (RA) relate to RA outcome measures and SF-36 population values? A cross-sectional study. Clin Rheumatol. 2000;19:195-9. (Pubitemid 30341252)
49. Del Rosso A, Boldrini M, D'Agostino D, Placidi GP, Scarpato A, Pignone A, et al. Health-related quality of life in systemic sclerosis as measured by the short form 36: relationship with clinical and biological markers. Arthritis Rheum. 2004;51:475-81. (Pubitemid 38725150)
50. Hudson M, Steele R, Lu Y, Thombs BD, Panopalis P, Baron M. Canadian Scleroderma research group. Clinical correlates of selfreported physical health status in systemic sclerosis. J Rheumatol. 2009;36:1226-9.
51. Dekkers JC, Geenen R, Godaert GL, Glaudemans F, Lafeber F, Doornen LJ, et al. Experimentally challenged reactivity of the hypothalamic pituitary adrenal axis in patients with recently diagnosed rheumatoid arthritis. J Rheumatol. 2001;28:1496-504. (Pubitemid 32660619)
52. Yoshino S, Mukai J, Kohda M. Effects of mirthful laughter on neuroendocrine and immune systems in patients with rheumatoid arthritis. J Rheumatol. 1996;23:793-4.
53. Lorig K, Lubeck D, Kraines R, Seleznick M, Holman H. Outcomes of self-help education for patients with arthritis. Arthritis Rheum. 1985;28:680-5. (Pubitemid 15059079)
54. Lorig K, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003;26:1-7.
55. Rhee SH, Parker JC, Smarr KL, Petroski GF, Johnson JG, Hewett JE, et al. Stress management in rheumatoid arthritis: what is the underlying mechanism? Arthritis Care Res. 2000;13:435-42. (Pubitemid 32003390)
56. Kate L, David S, Ritter P, Laurent D, Hobbs M. Effect of a selfmanagement program on patients with chronic disease. Eff Clin Pract. 2001;4:256-62.
57. Matsuura E, Ohta A, Kanegae F, Haruda Y, Ushiyama O, Koarada S, et al. Frequency and analysis of factors closely associated with the development of depressive symptoms in patients with scleroderma. J Rheumatol. 2003;30:1782-987.